<DOC>
	<DOCNO>NCT00898066</DOCNO>
	<brief_summary>RATIONALE : Studying chromosome sample bone marrow blood laboratory patient cancer blood disease may help doctor learn disease . PURPOSE : This laboratory study analyze chromosome patient newly diagnose multiple myeloma blood disease .</brief_summary>
	<brief_title>S0334 Analyzing Chromosomes Patients With Newly Diagnosed Multiple Myeloma Other Blood Disease</brief_title>
	<detailed_description>OBJECTIVES : - Compare frequency deletion 13 detect fluorescence situ hybridization ( FISH ) conventional cytogenetics patient newly diagnose multiple myeloma ( MM ) monoclonal gammopathy ( MG ) . - Examine prognostic value specific subsets chromosome aberration detect conventional cytogenetics FISH relation event-free overall survival patient . - Compare prognostic value cytogenetics FISH MM MG prognostic factor patient . - Correlate presence cytogenetic FISH feature clinical pathophysiological , cellular , molecular characteristic patient . OUTLINE : Patients receive treatment direct treatment clinical trial register . Patients undergo bone marrow blood sample collection periodically conventional cytogenetic analysis fluorescence situ hybridization study ( FISH ) . Samples analyze delete 13q/monosomy 13 chromosomal abnormality . PROJECTED ACCRUAL : A total 500 patient accrue study .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Plasmacytoma</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis 1 following : Multiple myeloma ( MM ) Smoldering myeloma Waldenstrom 's macroglobulinemia ( WM ) Monoclonal gammopathy undetermined significance ( MGUS ) Amyloidosis ( AL ) Newly diagnose disease Must currently register , begin therapy , 1 follow Southwest Oncology Group ( SWOG ) treatment clinical trial : SWOGS0115 SWOGS0232 SWOGS0340 All new SWOG coordinate MM , smolder myeloma , WM , MGUS , AL clinical trial activate activation date research study ( SWOGS0334 ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Waldenstrom macroglobulinemia</keyword>
	<keyword>monoclonal gammopathy undetermined significance</keyword>
	<keyword>primary systemic amyloidosis</keyword>
	<keyword>stage I multiple myeloma</keyword>
	<keyword>stage II multiple myeloma</keyword>
	<keyword>stage III multiple myeloma</keyword>
</DOC>